Actively Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
Led by Fundacio Puigvert · Updated on 2025-03-11
600
Participants Needed
24
Research Sites
118 weeks
Total Duration
On this page
Sponsors
F
Fundacio Puigvert
Lead Sponsor
E
European Association of Urology Research Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The RING study is a European registry collecting real-world data on advanced prostate cancer (APC) imaging. It aims to evaluate the role of next-generation imaging (NGI), such as PET/CT and whole-body MRI, in detecting and monitoring the disease compared to conventional imaging. Men aged 18 or older with histologically confirmed prostate cancer are eligible to participate in the study if they require imaging to assess potential metastases, either at diagnosis or after relapse and sign a consent form. Patients will receive standard care with no experimental treatments. Imaging and treatment decisions will follow routine clinical practice. Data will be collected from medical records and analysed for research. This study will help doctors understand when NGI should be used, how it affects treatment decisions, and its impact on patient outcomes.
CONDITIONS
Official Title
European Registry of Next Generation Imaging in Advanced Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult male patients 18 years or older with no upper age limit
- Histologically confirmed prostate cancer
- Patients requiring imaging exploration (conventional, NGI, or combination) at high risk for metastatic deposits at hormone-sensitive stage, either at initial diagnosis or biochemical relapse after local treatment
- Patients who sign a written informed consent form to participate
You will not qualify if you...
- Participation in other studies requiring NGI as a triage test for metastatic assessment
- Presence of any other clinically significant disease or condition that discourages participation according to the investigator
- Inability to complete the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 24 locations
1
Universitair Ziekenhuis Leuven
Leuven, Belgium
Not Yet Recruiting
2
Hospital Center University De Lille
Lille, France
Not Yet Recruiting
3
Hospices Civils de Lyon
Lyon, France
Not Yet Recruiting
4
University Hospitals Pitié Salpêtrière
Paris, France
Not Yet Recruiting
5
Bonn University Hospital
Bonn, Germany
Not Yet Recruiting
6
Martini Klinik
Hamburg, Germany
Not Yet Recruiting
7
München LMU L MU-University Clinic
Munich, Germany
Not Yet Recruiting
8
Urologische Klinik München - Planegg
Planegg, Germany
Not Yet Recruiting
9
Universitätsklinik Tübingen
Tübingen, Germany
Not Yet Recruiting
10
IRCCS Universit of Bologna
Bologna, Italy
Not Yet Recruiting
11
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
Actively Recruiting
12
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
Not Yet Recruiting
13
IRCCS Ospedale San Raffaele
Milan, Italy
Not Yet Recruiting
14
ERASMUS MC & Franciscus Hospital
Rotterdam, Netherlands
Not Yet Recruiting
15
Uniwersytet Jagielloński Collegium Medicum
Krakow, Poland
Not Yet Recruiting
16
Fundació Puigvert
Barcelona, Spain
Actively Recruiting
17
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Actively Recruiting
18
Hospital Universitario Reina Sofia
Córdoba, Spain
Not Yet Recruiting
19
Hospital Universitario La Paz
Madrid, Spain
Not Yet Recruiting
20
Hospital Universitario Ramón y Cajal
Madrid, Spain
Not Yet Recruiting
21
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Spain
Actively Recruiting
22
Hospital Universitario Marqués de Valdecilla
Santander, Spain
Not Yet Recruiting
23
Hospital Clínico Universitario de Santiago
Santiago de Compostela, Spain
Not Yet Recruiting
24
Skånes universitetssjukhus Malmö
Malmö, Sweden
Not Yet Recruiting
Research Team
F
Francesco Sanguedolce, MD, PhD
CONTACT
D
Daria Chernysheva, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here